Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Today, we talk more about Merck and Moderna’s potentially field-changing cancer vaccine, see a couple FDA approvals, and learn more about the new FDA commissioner nominee. Plus, brain organoids have stayed alive — and continue to mature — in a Harvard lab for five years. I wonder, actually, about the poor little brain organoids in Megan’s story. Just pulsing in their Petri dishes, contemplating moral relativity or migraines. It’s all very Robin Cook. Continue to STAT+ to…
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Today, we talk more about Merck and Moderna’s potentially field-changing cancer vaccine, see a couple FDA approvals, and learn more about the new FDA commissioner nominee. Plus, brain organoids have stayed alive — and continue to mature — in a Harvard lab for five years.
I wonder, actually, about the poor little brain organoids in Megan’s story. Just pulsing in their Petri dishes, contemplating moral relativity or migraines. It’s all very Robin Cook.
Continue to STAT+ to read the full story…
US Pharma Marketing